114 related articles for article (PubMed ID: 2684300)
41. Intracellular immunization. Cloning and intracellular expression of a monoclonal antibody to the p21ras protein.
Werge TM; Biocca S; Cattaneo A
FEBS Lett; 1990 Nov; 274(1-2):193-8. PubMed ID: 2123805
[TBL] [Abstract][Full Text] [Related]
42. Interactions between p21ras proteins and their GTPase activating proteins.
Polakis P; McCormick F
Cancer Surv; 1992; 12():25-42. PubMed ID: 1386285
[TBL] [Abstract][Full Text] [Related]
43. The antitumor efficacy of anti-p21Ras scFv mediated by the dual-promoter-regulated recombinant adenovirus KGHV300.
Pan XY; Liu XJ; Li J; Zhen SJ; Liu DX; Feng Q; Zhao WX; Luo Y; Zhang YL; Li HW; Yang JL
Gene Ther; 2017 Jan; 24(1):40-48. PubMed ID: 27834948
[TBL] [Abstract][Full Text] [Related]
44. The antitumor efficacy of a novel adenovirus-mediated anti-p21Ras single chain fragment variable antibody on human cancers in vitro and in vivo.
Yang JL; Pan XY; Zhao WX; Hu QC; Ding F; Feng Q; Li GY; Luo Y
Int J Oncol; 2016 Mar; 48(3):1218-28. PubMed ID: 26780944
[TBL] [Abstract][Full Text] [Related]
45. Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer.
Bai S; Feng Q; Pan XY; Zou H; Chen HB; Wang P; Zhou XL; Hong YL; Song SL; Yang JL
Int J Mol Med; 2017 Apr; 39(4):861-868. PubMed ID: 28259994
[TBL] [Abstract][Full Text] [Related]
46. Aberrant expression of p21RAS but not p120GAP is a common feature of myelodysplasia.
Gallagher A; Padua RA; al-Sabah A; Hoy T; Burnett AK; Darley RL
Leukemia; 1995 Nov; 9(11):1833-40. PubMed ID: 7475271
[TBL] [Abstract][Full Text] [Related]
47. Regulation of platelet-derived growth factor signaling by activated p21Ras.
Stice LL; Vaziri C; Faller DV
Front Biosci; 1999 Jan; 4():D72-86. PubMed ID: 9889183
[TBL] [Abstract][Full Text] [Related]
48. MHC class I antigen expression is inversely related with tumor malignancy and ras oncogene product (p21ras) levels in human breast tumors.
Solana R; Romero J; Alonso C; Peña J
Invasion Metastasis; 1992; 12(3-4):210-7. PubMed ID: 1294532
[TBL] [Abstract][Full Text] [Related]
49. The p21ras protein as an intermediate signaling molecule in the IL-4-induced HLA-DR expression on normal and leukemic human myeloid cells.
Vassiliadis S; Papamatheakis J
Cell Immunol; 1992 Jul; 142(2):426-33. PubMed ID: 1377987
[TBL] [Abstract][Full Text] [Related]
50. Quantitative immunofluorescence, anti-ras p21 antibody specificity, and cellular oncoprotein levels.
Jones PL; O'Hare CM; Bass RA; Rao JY; Hemstreet GP; Hurst RE
Biochem Biophys Res Commun; 1990 Mar; 167(2):464-70. PubMed ID: 2138889
[TBL] [Abstract][Full Text] [Related]
51. Expression of p21 ras protein in human melanoma cell lines.
Funato T; Take A; Ichikawa K; Ohtani H; Kankazi T
Neoplasma; 1989; 36(5):513-8. PubMed ID: 2682295
[TBL] [Abstract][Full Text] [Related]
52. p21ras induced differentiation-related gene expression in fetal brown adipocyte primary cells and cell lines.
Lorenzo M; Valverde AM; Teruel T; Alvarez A; Benito M
Cell Growth Differ; 1996 Sep; 7(9):1251-9. PubMed ID: 8877105
[TBL] [Abstract][Full Text] [Related]
53. Induction and characterization of cytotoxic T-lymphocytes recognizing a mutated p21ras peptide presented by HLA-A*0201.
Van Elsas A; Nijman HW; Van der Minne CE; Mourer JS; Kast WM; Melief CJ; Schrier PI
Int J Cancer; 1995 May; 61(3):389-96. PubMed ID: 7729952
[TBL] [Abstract][Full Text] [Related]
54. ras isoprenylation is required for ras-induced but not for NGF-induced neuronal differentiation of PC12 cells.
Qiu MS; Pitts AF; Winters TR; Green SH
J Cell Biol; 1991 Nov; 115(3):795-808. PubMed ID: 1918164
[TBL] [Abstract][Full Text] [Related]
55. [Quantitative study of oncogene p21ras expression in premalignant lesion and carcinoma of the stomach].
Zuo LF; Qi FY; Guo JW
Zhonghua Bing Li Xue Za Zhi; 1994; 23(3):138-40. PubMed ID: 7954950
[TBL] [Abstract][Full Text] [Related]
56. p21ras-mediated decrease of the retinoblastoma protein in fibroblasts occurs through growth factor-dependent mechanisms.
Kivinen L; Tiihonen E; Haapajärvi T; Laiho M
Cell Growth Differ; 1996 Dec; 7(12):1705-12. PubMed ID: 8959339
[TBL] [Abstract][Full Text] [Related]
57. Immunocytochemical study of RAS oncoprotein in cytologic specimens of primary lung tumours.
Koutselini H; Kappatou G; Yiagnisis M; Field JK; Spandidos DA
Anticancer Res; 1990; 10(3):597-603. PubMed ID: 2164347
[TBL] [Abstract][Full Text] [Related]
58. p21ras independent down-regulation of ras-induced increases in natural antibody binding during tumor progression.
Tough DF; Feng X; Chow DA
Nat Immun; 1995; 14(1):20-34. PubMed ID: 7599459
[TBL] [Abstract][Full Text] [Related]
59. Cooperativity of SV40 T antigen and ras in progressive stages of transformation of human fibroblasts.
White JA; Carter SG; Ozer HL; Boyd AL
Exp Cell Res; 1992 Nov; 203(1):157-63. PubMed ID: 1330654
[TBL] [Abstract][Full Text] [Related]
60. [Oncogenic activation of p21ras or pp60c-src in human colonic Caco-2 cells induces post-translation alterations of syndecan-1].
Lévy P; Munier A; Baron-Delage S; Chastre E; Gespach C; Capeau J; Cherqui G
Bull Cancer; 1997 Mar; 84(3):235-7. PubMed ID: 9207867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
